News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2018/Richardt_Gert_GERMANY_web.jpg)
Rotablation aids in prepping highly calcified lesions: PREPARE-CALC
- Author:
- Susan London
SAN DIEGO – Preparatory rotational atherectomy’s early edge over modified balloon may not last.
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Prosthesis-patient mismatch post TAVR ups death risk 19%
- Author:
- Susan London
SAN DIEGO – About one in eight patients have severe PPM after undergoing TAVR, according to the largest study to date of this population.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2018/Krucoff_Mitchell_W_NC_web.jpg)
Drug-coated stent bests bare metal in patients with high bleeding risk
- Author:
- Susan London
SAN DIEGO – Positive results of the LEADERS FREE II trial in patients at high bleeding risk undergoing PCI bode...
News
Study sheds new light on prognostic factors in PRCC
- Author:
- Susan London
PRCC subtypes 1 and 2 have differing histologic features and immunohistochemical profiles, but subtype does not independently predict overall...
News
Meta-analysis supports rituximab maintenance in MCL
- Author:
- Susan London
Rituximab maintenance therapy prolonged progression-free survival. Risk of grade 3 or 4 neutropenia was increased, but risk of infection was not...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/apheresis-machine-luis-alvaz-230.jpg)
Auto-HSCT linked to higher AML, MDS risk
- Author:
- Susan London
Patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) for lymphoma or myeloma have an increased risk of acute myeloid...
News
Autotransplant is linked to higher AML, MDS risk
- Author:
- Susan London
For patients with lymphoma or plasma cell myeloma, autologous hematopoietic cell transplantation was linked to marked increases in the risk of AML...
Article
Broad genomic testing of NSCLC in community oncology disappoints
- Author:
- Susan London
Among patients with advanced NSCLC treated in community oncology practices, broad-based genomic sequencing seldom exclusively informed the...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/July-2018/Thompson_Michael_web.jpg)
Trio of biosimilars have good showing
- Author:
- Susan London
CHICAGO – Biosimilars for three widely used oncology drugs showed efficacy and safety similar to those of the reference products in lung cancer...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/July-2018/133856_Kolberg.jpg)
Trastuzumab biosimilar is equivalent on central review
- Author:
- Susan London
CHICAGO – In a 20-country neoadjuvant trial, findings when tissue was centrally reviewed differed somewhat from those when tissue was reviewed...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/Bisogno_Gianni_ITALY_web.jpg)
Youth with rhabdomyosarcoma see better survival with maintenance chemo
- Author:
- Susan London
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
New cell-free DNA assays hold promise for lung cancer screening
- Author:
- Susan London
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/Katzel_Jed_A_web.jpg)
H&N cancer may be undertreated in women
- Author:
- Susan London
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/Sparano_Joseph_A_NEWYORK_web.jpg)
TAILORx marks major advance for precision medicine in breast cancer
- Author:
- Susan London
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate...
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/rhabdo.jpg)
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
- Author:
- Susan London
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...